Indian Pharmaceuticals & Biotech Most Popular Stocks

Sun Pharmaceutical Industries

Market Cap: ₹4.1t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Divi's Laboratories

Market Cap: ₹1.6t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.4t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Cipla

Market Cap: ₹1.1t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Dr. Reddy's Laboratories

Market Cap: ₹1.0t

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Lupin

Market Cap: ₹999.1b

Operates as a pharmaceutical company in India, the United States, and internationally.

Zydus Lifesciences

Market Cap: ₹908.5b

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

Mankind Pharma

Market Cap: ₹892.7b

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally.

Aurobindo Pharma

Market Cap: ₹712.1b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Alkem Laboratories

Market Cap: ₹681.8b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Biocon

Market Cap: ₹602.5b

Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.

Abbott India

Market Cap: ₹571.0b

Operates as a pharmaceutical company in India.

Glenmark Pharmaceuticals

Market Cap: ₹551.5b

Develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally.

Laurus Labs

Market Cap: ₹526.7b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹412.5b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Ipca Laboratories

Market Cap: ₹364.1b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.

Ajanta Pharma

Market Cap: ₹359.7b

A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.

Anthem Biosciences

Market Cap: ₹341.1b

Operates as technology-focused contract research, development, and manufacturing organization.

Gland Pharma

Market Cap: ₹312.3b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹304.2b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Emcure Pharmaceuticals

Market Cap: ₹285.5b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Wockhardt

Market Cap: ₹219.4b

Operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally.

AstraZeneca Pharma India

Market Cap: ₹217.4b

A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

Piramal Pharma

Market Cap: ₹214.1b

Operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

Pfizer

Market Cap: ₹213.5b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

Eris Lifesciences

Market Cap: ₹199.6b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Syngene International

Market Cap: ₹190.3b

A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

Sai Life Sciences

Market Cap: ₹185.7b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Neuland Laboratories

Market Cap: ₹171.5b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹161.3b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Jubilant Pharmova

Market Cap: ₹156.6b

Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.

Alembic Pharmaceuticals

Market Cap: ₹155.6b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

NATCO Pharma

Market Cap: ₹152.9b

A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

Cohance Lifesciences

Market Cap: ₹145.6b

Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.

Caplin Point Laboratories

Market Cap: ₹141.5b

Engages in the development, production, marketing, and export of generic formulations and branded products in India.

Granules India

Market Cap: ₹138.7b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.